Error: Could not add to watchlist. X
+ Watchlist

MabVax Therapeutics Holdings Inc

TK8N:GR
Ticker Delisted
EUR
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.50%
% Price Change
+0.53%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
MabVax Therapeutics Holdings Inc. is a clinical stage oncology drug development company focused on the development of human antibody-based products and vaccines to address unmet medical needs in the treatment of cancer.
Address
11588 Sorrento Valley Road
Suite 20
San Diego, CA 92121
United States
Phone
1-858-259-9405
  • J David Hansen
    Chairman/Pres/CEO/Co-Founder
  • Gregory P Hanson
    Chief Financial Officer
  • Philip O Livingston
    Chief Science Officer
  • Paul W Maffuid
    Exec VP:Research & Development
  • Paul F Resnick
    VP/Chief Business Officer
Show More